Signify N.V. (ENXTAM:LIGHT) entered into an agreement to acquire Fluence Bioengineering, Inc. from OSRAM Licht AG (HMSE:OSR) for approximately $270 million on December 20, 2021. Fluence team will be joining Signify N.V. The acquisition is expected to close in the first half of 2022, subject to regulatory approvals and other conditions. In the trailing 12 months (October 2020 to September 2021),Fluence generated USD 141 million.

Signify N.V. (ENXTAM:LIGHT) completed the acquisition of Fluence Bioengineering, Inc. from OSRAM Licht AG (HMSE:OSR) May 2, 2022.